rs838133

badMag 3.5

This is a intergenic variant variant in the FUT2 gene.

Key Literature Trait Associations

Sweet Food Preference

Each copy of the A allele at rs838133 is associated with increased preference for sweet-tasting foods and higher sugar intake. This variant lies in the FUT1/FUT2 locus encoding fucosyltransferases involved in gut mucosal glycosylation and microbiome composition, which may influence taste perception and dietary behavior. The association was identified in a GWAS meta-analysis of 91,114 European ancestry participants from the CHARGE consortium.

Allele A
OR
β 0.080
p 2.4e-8
Meta-analysisMajor Consortium Study
Chu AY et al. Novel locus including FGF21 is associated with dietary macronutrient intake. Human Molecular Genetics 22(9):1895-902 (2013)
Allele A
OR
p 7.9e-9
N 71,893
Large GWAS
multi-ancestry
Allele A
OR
p
N 6,514
Preliminary work
Danish

Carbohydrate intake

The A allele at rs838133 consistently associates with a higher proportion of calories derived from carbohydrates across large GWAS and meta-analyses. The CHARGE/DietGen meta-analysis (n>71,000) reached genome-wide significance (p=7.9×10⁻⁹) for this phenotype, and the association was replicated in 451,099 UK Biobank participants. Mendelian randomization analyses using this locus confirm that FGF21 signaling causally influences macronutrient selection, with higher FGF21 activity linked to reduced carbohydrate preference and the A allele blunting that suppression. The effect appears to operate through FGF21's role as a sucrose-responsive hepatokine that modulates hypothalamic sweet-taste reward circuits.

Chu AY et al. Novel locus including FGF21 is associated with dietary macronutrient intake. Human Molecular Genetics 22(9):1895-902 (2013)
Allele A
OR
p 7.9e-9
N 71,893
Large GWAS
multi-ancestry
Allele A
OR
p
N 157,508
Preliminary work
European

Alcohol intake

The A allele at rs838133 has been associated with higher alcohol intake in multiple studies, although the signal is generally nominally significant rather than genome-wide in most individual cohorts. Søberg et al. (2017) observed nominal associations with increased alcohol intake alongside candy consumption in the Inter99 cohort. Larsson & Gill (2021) found the protective G allele associated with lower alcohol intake in Mendelian randomization analyses. Ramne et al. (2024) used genetic fine-mapping to show the rs838133 diet signal is distinct from the FGF21 protein pQTL, and that higher circulating FGF21 reduces alcohol intake, suggesting the A allele's effect may partly operate through reduced FGF21 signaling efficiency.

Allele A
OR
p
N 157,508
Preliminary work
European
Allele A
OR
p
N 6,514
Preliminary work
Danish

Waist-hip ratio

The A allele at rs838133 is paradoxically associated with lower total body-fat percentage but higher waist-hip ratio in 451,099 UK Biobank participants, indicating an unfavorable central fat distribution pattern. This dissociation suggests FGF21 influences not merely total adiposity but the regional partitioning of fat, with A allele carriers accumulating proportionally more abdominal fat. Mendelian randomization evidence from Larsson & Gill (2021) corroborates this, finding the protective G allele favorably associated with waist-to-hip ratio and cardiometabolic markers.

Blood pressure

The A allele at rs838133 associates with elevated blood pressure in the UK Biobank (n=451,099), representing one of the most prominent cardiometabolic findings beyond dietary phenotypes at this locus. This association is stronger than the variant's effect on BMI or type 2 diabetes, suggesting blood pressure may be a key downstream consequence of FGF21 pathway dysregulation. Larsson & Gill (2021) confirmed via Mendelian randomization that the protective G allele (lower sugar/alcohol intake) associates with favorable blood pressure traits, providing causal support for this relationship.

Metabolic dysfunction-associated steatohepatitis

A candidate-gene study by Gallego-Durán et al. (2024) found the A allele at rs838133 to be independently associated with MASH (metabolic dysfunction-associated steatohepatitis) and significant hepatic fibrosis in MASLD patients, across both estimation and validation cohorts. The biological rationale is compelling given FGF21's established hepatoprotective role, but the study was small (89 MASLD patients, 44 MASH patients, 28 controls) and requires replication in larger independent cohorts before clinical weight can be assigned.

Gallego-Durán R et al. Fibroblast growth factor 21 is a hepatokine involved in MASLD progression. United European Gastroenterology Journal (2024)
Allele A
OR
p
N 161
Candidate gene study
European

GWAS Catalog Trait Associations (59)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

Research that mentions this SNP (1)

Sugar-sweetened beverage intake associations with fasting glucose and insulin concentrations are not modified by selected genetic variants in a ChREBP-FGF21 pathway: a meta-analysis
Meta-analysisN=34,748McKeown NM et al.(2018)· Diabetologia

Meta-analysis of 34,748 European ancestry adults from 11 CHARGE Consortium cohorts examining sugar-sweetened beverage (SSB) intake associations with glycemic traits. SSB intake was associated with higher fasting glucose (β=0.014 mmol/l, p=1.5×10⁻³) and fasting insulin (β=0.030 log pmol/l, p=2.0×10⁻¹⁰). Although a suggestive interaction between SSB and KLB-rs1542423 was observed in discovery cohorts for fasting insulin (p=0.006), this was not confirmed in replication analysis.

Traits studied:Fasting glucoseFasting insulinGlycemic traitsType 2 diabetes

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…